Inno-Gene S.A. (WQ3.F)

0.3610 +0.0010 (+0.28%) At close: 03:29PM CEST

Inno-Gene S.A.

ul. Sciegiennego 20
Poznan 60-128
Poland
48 509 65 80 06
https://www.inno-gene.pl

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 10

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jacek Marek Wojciechowicz	President of the Management Board	N/A	N/A	N/A
Mr. Rafal Gebicki	Financial Director & Member of Management Board	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Inno-Gene S.A. provides genetic diagnostic solutions in Poland. It is involved in the research and diagnostic center implementation; and the provision of technologies in the field of DNA analysis. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of HPV-dependent solid tumors. In addition, it provides DNA analysis and genetic diseases diagnostic service based on NGS technology. Inno-Gene S.A. was incorporated in 2010 and is headquartered in Poznan, Poland.

Corporate Governance

Inno-Gene S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.